Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGENTEX GROUP PLC Regulatory Filings 2025

Jul 18, 2025

7495_rns_2025-07-18_71e96c07-f03a-4782-b21d-df08b685e515.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5750R

Argentex Group PLC

18 July 2025

18 July 2025

Argentex Group PLC

("Argentex" or the "Group")

Announcement of VREQ

Argentex Group PLC ("Argentex" or the "Group") announces that their main trading subsidiary, Argentex LLP, has agreed to a Voluntary Requirement ("VREQ") imposed by the FCA, which introduces a business restriction requiring it to cease all regulated activity, to not register and onboard new customers, and to not open any new foreign exchange trades. These restrictions also require the firm to take all reasonable steps to stop incoming payments from existing customers. These measures form part of the FCA's ongoing supervisory engagement with Argentex LLP following recent market volatility and liquidity pressures.

Enquiries:

Argentex Group plc

Tim Rudman - Interim Chief Executive Officer
c/o Teneo Financial Advisory Limited
Singer Capital Markets Advisory LLP (Nominated Adviser and Financial Adviser to Argentex)

Tom Salvesen

James Maxwell

James Todd
+44 (0) 20 7496 3000
Teneo Financial Advisory Limited (Capital Market Communications Ltd) (Financial PR Adviser to Argentex)

James Macey-White

Victoria Boxall

Riann Cato
+44 (0) 20 7260 2700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGPUWAMUPAPUM